We have shown that persistent expression of the chemokine receptor CXCR4 and Hh signal activation can predict very earlier relapse and poorer prognosis in ESCC patients after CRT [28,30]. The gene discussed is CXCR4; the disease is esophageal squamous cell carcinoma.